Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
F.D.A. Firings Decimated Teams Reviewing A.I. and Food Safety
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
technologynetworks3h
Sweeteners Linked to Blood Vessel Inflammation, But Experts Urge Caution
Does aspartame increase heart disease risk? A new study in mice suggests a link, but experts caution against jumping to ...
ophthalmologyadvisor6h
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
News Medical8h
The dangers of fraudulent diabetes products and how to avoid them
As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...
Medscape9h
How Can Machine Learning Boost T1D Patients’ Time in Range?
The Helmsley Charitable Trust’s T1D Exercise Initiative ( T1-DEXI) datasets provide baseline information on the glycemic ...